Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000188

Director sold 8,000 shares at $75.67 ($605,360)

  • Director acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BERTHELSEN SPENCER R · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-01 Exercise or conversion : show line 1 in the form 10b5-1 +8,000 $24.42 $195,360 164,013 D
2026-06-01 Sale : show line 2 in the form 10b5-1 −8,000 $75.67 $605,360 156,013 D
Open-market sales · 8,000 sh · avg $75.67 · $605,360

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-01 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −8,000 8,000 D
Loading xslF345X06/edgardoc.xml…